Related Experiment Videos
Sacral neuromodulation for treatment of lower urinary tract dysfunction
M Hohenfellner1, S E Dahms, K Matzel
1Department of Urology, University of Mainz, Mainz, Germany.
BJU International
|April 17, 2002
Summary
Sacral neuromodulation offers a minimally invasive treatment for lower urinary tract dysfunction, showing significant effects for urge syndromes and emptying issues. Patients require test stimulation due to unpredictable efficacy, with conservative options recommended first.
Area of Science:
- Urology
- Neuromodulation
- Pelvic Health
Background:
- Lower urinary tract dysfunction (LUTD) presents a significant clinical challenge.
- Current treatments range from conservative measures to invasive surgeries like urinary diversion.
- Sacral neuromodulation (SNM) emerges as an intermediate therapeutic option.
Purpose of the Study:
- To evaluate the efficacy and safety of sacral neuromodulation for LUTD.
- To identify patient populations most likely to benefit from SNM.
- To establish the role of SNM within the spectrum of LUTD treatment.
Main Methods:
- Review of clinical trials evaluating SNM for LUTD.
- Focus on unilateral sacral foramen electrode implantation.
- Comparison of SNM outcomes against control groups.
Main Results:
- SNM demonstrated statistically significant therapeutic effects for urge syndromes and failure to empty.
- Patients with detrusor hyperactivity or hypo-activity showed the best response.
- Pain syndromes were associated with a lower likelihood of benefit.
Conclusions:
- SNM is a viable treatment for specific LUTD, bridging conservative and invasive approaches.
- Test stimulation is crucial for predicting individual patient response.
- Exhausting conservative therapies before considering SNM is recommended due to long-term efficacy uncertainties.